1. Introduction {#sec1}
===============

The endoplasmic reticulum (ER) is an essential organelle of eukaryotic cells functioning in secretory protein synthesis and processing, lipid synthesis, calcium storage/release, and detoxification of drugs. The ER ensures correct protein folding and maturation. Unfolded proteins are retained in the ER and targeted for retrotranslocation to the cytoplasm for rapid degradation. Under normal physiological conditions, there is a balance between the unfolded proteins and the ER folding machinery. Disruption of the balance results in accumulation of unfolded proteins, a condition termed ER stress \[[@B1]--[@B5]\]. The ER stress triggers the unfolded protein response (UPR), which attenuates protein translation, increases protein folding capacity, and promotes degradation of unfolded proteins, thus restoring ER homeostasis. However, prolonged UPR leads to an attempt to delete the cell causing injuries. Molecular chaperones such as the glucose-regulated protein 78 (GRP78/BiP) interact with three ER membrane resident stress sensors: inositol-requiring enzyme-1 (IRE1*α*), transcription factor-6 (ATF6), and PKR-like eukaryotic initiation factor 2*α* kinase (PERK), and play a vital role in maintaining the protein homeostasis inside the ER \[[@B1]--[@B5]\]. Many human diseases such as metabolic syndrome, neurodegenerative diseases, alcohol-induced organ disorders, and inflammatory diseases involve ER stress and impaired UPR signaling \[[@B1]--[@B7]\]. Increasing evidence supports ER stress as a key mechanism in alcohol-induced liver disease (ALD), a disease that affects over 140 million people worldwide. Potential molecular mechanisms underlying alcohol-induced ER stress in major organs including liver, brain, pancreas, lung, and heart have been discussed previously \[[@B8]--[@B10]\]. In this review, I will focus on updates and new insights into the pathogenesis of alcohol-induced ER stress and discuss an emerging role of alcohol-induced ER stress in liver tumorigenesis and hepatocellular carcinogenesis.

2. Multiple Mechanisms for Alcohol-Induced Hepatic ER Stress {#sec2}
============================================================

Alcohol is mainly metabolized in the liver and liver cells are rich in ER, which assume synthesis of a large amount of secretory and membrane proteins. The UPR plays a pivotal role in maintaining ER homeostasis in the liver under both physiological and pathological conditions \[[@B4], [@B5], [@B9]\]. In the early 80s, stress-induced ER damages in the liver were observed in ultrastructural, morphological, and histological studies \[[@B11], [@B12]\]. However, little was known then about occurrence and mechanisms of alcohol-induced ER stress. A role of ER in alcohol metabolism began to be recognized as NADH from the hepatic alcohol oxidation by alcohol dehydrogenase (ADH) was also found to support microsomal alcohol oxidations \[[@B11]--[@B14]\]. The inducible microsomal ethanol oxidizing system (MEOS) is associated with ER proliferation and concomitant induction of cytochrome P4502E1 (CYP2E1) in rats and in humans \[[@B13], [@B14]\]. Free radical release, as a consequence of CYP2E1 activities in the ER and subsequent oxidative stress, and lipid peroxidation generally contribute to ALD. However, alcohol-induced ER stress response (AERR) that involves the UPR was not recognized until recently. Molecular evidence for an impaired UPR was first found in the mice with chronic intragastric alcohol infusion (CIAI) ([Figure 1](#fig1){ref-type="fig"}; [Table 1](#tab1){ref-type="table"}) \[[@B15]\]. Alterations of some ER stress markers: GRP78, GRP94, CHOP (C/EBP homologous protein), and BAD (the Bcl-2-associated death promoter), in DNA microarrays were associated with severe steatosis, scattered apoptosis, and necroinflammation. SREBP-1c (sterol regulatory element-binding protein-1c) was found to be a strong candidate linking ER stress to alcoholic fatty liver, because SREBP-1c knockout mice were protected against triglyceride accumulation \[[@B16]\]. CHOP was found to be a key factor in AERR-caused cell death, as knocking out CHOP resulted in minimal alcohol-induced apoptosis in the liver \[[@B17]\].

Upstream of ER stress, altered methionine metabolism, and elevated homocysteine were initially proposed to be responsible for AERR because alcohol-induced hyperhomocysteinemia (HHcy) is often seen in rodents and humans \[[@B18]--[@B21]\] and homocysteine is known to modify proteins biochemically \[[@B8], [@B9], [@B15]\]. A few lines of molecular evidence support the methionine/homocysteine mechanism. First, betaine is a methyl donor for remethylation of homocysteine to methionine catalyzed partially by betaine-homocysteine methyltransferase (BHMT). Simultaneous betaine feeding or transgenic expression of BHMT in CIAI mice decreased the elevated homocysteine and abrogated AERR in parallel with decreased ALT and amelioration of ALD \[[@B15], [@B22], [@B23]\]. Second, an intragastric infusion with both high fat and alcohol induced moderate obesity and much severe ALD \[[@B24]\], which resulted from synergistic effects of an accentuated ER stress by the alcohol-induced HHcy in combination with mitochondrial stress, nitrosative stress, and adiponectin resistance. Third, rats with CIAI do not have a significant HHcy \[[@B25]\]. Consequently, the rat animals have a minimal ER stress response and are more resistant to ALD, which correlates with a significant induction of BHMT. Fourth, in a study with 14 inbred mouse strains with CIAI, profound differences in ALD were observed among the strains in spite of consistently high levels of urine alcohol \[[@B26]\]. ER stress related genes were induced only in strains with the most liver injury, which were closely associated with expression patterns of methionine metabolism-related genes and plasma homocysteine levels. Thus, abnormal protein modifications by excessive homocysteine as a result of aberrant one-carbon metabolism \[[@B26]\] and methionine deficiency \[[@B4]\] are likely responsible for the alcoholic ER stress and UPR in CIAI mice that lack a sufficient upregulation of BHMT.

However, other causes for the alcoholic ER stress are present in the CIAI model. For instance, in a study with CIAI rats to examine effects of selective inhibition of CYP2E1 on the development of alcoholic fatty liver \[[@B27]\], liver triglycerides were lower. ER stress indicated by the ER stress marker TRB3 (a mammalian homolog of*Drosophila* tribbles functions as a negative modulator of protein kinase B) was increased after ethanol and was further increased upon inhibition of CYP2E1 or overall ethanol metabolism. This suggests a contributing role of alcohol metabolites, for example, acetaldehyde, or oxidants to the alcoholic ER stress response. In another study with cystathionine *β* synthase (CBS) heterozygous mice treated with CIAI \[[@B28]\], steatohepatitis was accompanied with upregulations of hepatic ER stress components including GRP78, ATF4 (activating transcription factor 4), CHOP, and SREBP-1c and negatively correlated with S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) ratio. AERR was associated with a decrease in levels of suppressor chromatin marker trimethylated histone H3 lysine-9 (3meH3K9) in the promoter regions of the ER stress markers. Similarly, epigenetic mechanism for AERR might also occur in human alcoholics, as DNA hypermethylation of the promoter of HERP (homocysteine-induced ER protein) gene downregulates its mRNA expression in patients with alcohol dependence \[[@B29]\].

3. Diverse Models and Species with Alcohol-Induced ER Stress {#sec3}
============================================================

AERR occurs not only in the aforementioned CIAI models but also in other chronic or acute models/systems ([Table 1](#tab1){ref-type="table"}), which have been providing additional insights into AERR and ALD. In micropigs fed alcohol orally \[[@B30]\], liver steatosis and apoptosis were shown to be accompanied by increased mRNA levels of CYP2E1 and selective ER stress markers. Folate deficiency appeared to be responsible for the ER stress and injury. In mice, however, oral alcohol feeding*ad libitum* does not usually result in HHcy as remarkable as seen in the CIAI mice. Correspondingly, the degree of AERR and subsequent liver injury may depend on additional genetic and/or dietary factors. For instance, in the mice with liver specific deletion of GRP78/BiP \[[@B31]\], a robust ER stress response was observed at moderate oral alcohol doses (e.g., 4 g/kg), which was accompanied by much aggravated hepatosteatosis and hepatic fibrosis. Thus, compared to the homocysteine-ER stress mechanism, the liver BiP deletion represents a genetic predisposition that unmasks a distinct mechanism by which alcohol induces ER stress, one that is largely obscured by compensatory changes in normal animals or presumably in the majority of human population who have low-to-moderate drinking \[[@B8], [@B31]\]. The effect of genetic predisposition on AERR and hepatic injury is also observed in a recent study using mice with low alcohol-induced plasma homocysteine and deficient in the acid sphingomyelinase (ASMase) \[[@B32]\]. Strong AERR and enhanced susceptibility to lipopolysaccharides (LPS) or concanavalin-A were present in ASMase ^−^/^−^ mice fed alcohol orally, indicative of a mitochondrial effect on AERR. In addition, in iron overloaded mice deficient in the hemochromatosis gene (Hfe^−^/^−^), cofeeding*ad libitum* with alcohol and a high-fat diet (HFD) led to profound steatohepatitis and fibrosis \[[@B33], [@B34]\]. XBP1 splicing, activation of IRE-1*α* and PERK, and increased CHOP protein expression were associated with impaired autophagy response, suggesting that preconditioning with iron overloading may modulate AERR and promote liver injury through interacting with other adaptive or compensatory mechanisms.

Alternatively, the contributing role of ER stress to ALD in oral feeding models could be secondary. This is indicated by a time-course study with a mouse model of early-stage ALD \[[@B35]\]. Mice with oral alcohol feeding exhibited significant hepatic steatosis and elevated plasma ALT values. At 1 to 2 weeks after alcohol feeding, oxidative stress indicated by 4-hydroxynonenal- (4-HNE-) modified proteins was increased, whereas hepatic glutathione (GSH) levels were significantly decreased as a consequence of decreased CBS activity, increased GSH utilization, and increased protein glutathionylation. Except for 4-HNE adduction to the ER disulfide isomerase (PDI), significant upregulations of other ER markers and SREBP pathways were not detected*in vivo* during the same early period of alcohol feeding \[[@B35], [@B36]\]. Although the actual blood alcohol levels were not measured in this study, which might not reach a critical point and vary widely among individual mice at a liberal access to alcohol, the results may suggest a secondary role of AERR in this early ALD model. Thus, interplay or cross-talk between AERR and other stresses might be critical in ALD. This notion is supported by a few most recent reports, which appears more evident in cell or animal models with acute alcohol exposure. First, cell death is not readily observed in acute ethanol intoxication. However, in a perfused rat liver system, downregulation of GRP78 and activation of c-Jun N-terminal kinase (JNK) and protein kinase B (PKB/Akt) were enhanced by a cotreatment of acute ethanol with a classical inhibitor of ADH, and an antioxidant addition reduced the activation of JNK and cell death \[[@B37]\]. High concentrations of the pharmacological ER stress-inducing agents such as tunicamycin or brefeldin A activate JNK and inhibit mitochondrial respiration and cell death in hepatocytes \[[@B38]\]. Mitochondrial respiration has been shown to play an adaptive role in ALD \[[@B39]\]. Thus, ethanol metabolites and/or impaired mitochondrial functions may complicate AERR. Second, the mice with liver specific GRP78 deletion are sensitized to a variety of acute hepatic disorders by alcohol, a high-fat diet, anti-HIV drugs, or toxins \[[@B31]\]. HIV protease inhibitors inhibit the ER Ca^2+^ATPase (SERCA) and modulate calcium homeostasis in mice and primary human hepatocytes, which aggravates AERR and ALD \[[@B40]\]. Alcohol-induced LPS impairs UPR promoting rat liver cirrhosis \[[@B41]\]. Third, the interferon regulatory factor 3 (IRF3) is activated early by ER stress in mice fed alcohol either orally or intragastrically, which involves an ER adaptor, the stimulator of interferon genes (STING) \[[@B42]\]. Independent of inflammatory cytokines and Type-I interferons (IFNs), IRF3 exerts its pathogenic role in ALD through causing apoptosis of hepatocytes, which strongly suggests that AERR pathways and the LPS-TLR4 (toll-like receptor 4) pathways \[[@B43]\] are parallel or equally important in initiating ALD.

In addition to rodents, AERR has also been found in other species including human alcoholics ([Table 1](#tab1){ref-type="table"}). Zebrafish larvae represent an alternative vertebrate model for studying AERR and ALD because their liver possesses the pathways to metabolize alcohol that can be simply added to the water, that is, acute alcohol \[[@B44]\]. AERR is present in alcohol-treated zebrafish, which may also interact with other pathological factors. Upon alcohol challenge, zebrafish larvae developed signs of acute ALD, including hepatomegaly and steatosis. Further, the ER stress response appeared much robust in zebrafish deficient in the CDP-diacylglycerol-inositol 3-phosphatidyltransferase (CDIPT) that primarily locates on the cytosolic aspect of the ER \[[@B45]\]. Thus, integrity of the ER or alcohol metabolism might be necessary for AERR \[[@B46]\]. In supporting this, in the species*Caenorhabditis elegans* without a liver for alcohol digestion/metabolism, little AERR has been detected \[[@B47]\]. The most important and clinically relevant studies regarding AERR are from human cells and patients. AERR is reported in human monocyte-derived dendritic cells (MDDC) \[[@B48]\], HepG2 cells expressing human CYP2E1 \[[@B49]\], and primary human hepatocytes \[[@B40]\]. Oxidative stress resulted from the function of CYP2E1 and/or interactions with other drugs contributing to AERR in the human cells. However, cultured human cell models may not reflect the complexity of the response*in vivo*. For instance, it was reported that, upon alcohol exposure, VL-17A cells metabolized alcohol which caused ER fragmentation inside the cells, but little activation of UPR target genes was detected \[[@B50]\]. Nevertheless, striking upregulation of multiple ER stress signaling molecules was detected in human patients with ALD ([Table 1](#tab1){ref-type="table"}) \[[@B51]--[@B54]\], which is correlated with deregulated lipid metabolism, ceramide accumulation, and impaired insulin signaling, indicating that AERR is an integrated part of pathogenesis of ALD in human alcoholics.

4. Emerging Role of AERR in Liver Tumorigenesis and HCC {#sec4}
=======================================================

It has been well accepted that the UPR is a double-edged response because both adaptive survival and eliminative apoptosis can be induced by UPR components \[[@B1]--[@B6]\]. It is beneficial or prosurvival if it happens transiently or lasts for a short period of time, whereas it is detrimental or deadly if it is prolonged. Recent studies indicate that the UPR is associated with solid tumor development in many types of tissues or organs including the liver \[[@B55], [@B56]\]. Since the microenvironments of solid tumors are generally hypoxic, acidic, and nutrient deficient \[[@B57], [@B58]\], which individually or collectively favor activation of ER stress response, it is conceivable that the UPR is persistently present during tumorigenesis. The question is how the cancer cells evade cell death from the prolonged UPR. Emerging evidence suggests that cancerous cells could modify and perturb the ER stress-associated cell death signaling, which permits survival and growth. For instance, the master regulator UPR, GRP78, plays a dual role in tumor cells \[[@B31], [@B59]\]. It controls early tumor development through suppressive mechanisms such as the induction of cell cycle arrest or tumor dormancy upon PERK activation \[[@B60]\]. On the other hand, at more advanced stages of tumor progression, during which cells are exposed to more severe stressors, GRP78 suppresses caspase 7 activation and interacts with ER stress-induced protein chaperones such as clusterin to promote cell survival and further tumor development \[[@B61]\]. The PERK-eIF2*α*-ATF4 pathway is often activated by the hypoxic condition in solid tumors \[[@B62]--[@B64]\], which activates angiogenic genes, vascular endothelial growth factor (VEGF), type 1 collagen inducible protein, and autophagosome components such as LC3, ensuring cell survival over hypoxia-induced ER stress \[[@B65]--[@B67]\]. Prolonged expression and activation of ATF6 increase the Rheb-mTOR signaling pathway and also enhance tumor cell survival \[[@B68]\]. In addition, the IRE1*α*-Xbp1 pathway interacts with antiapoptotic Bcl-2 family members and the sigma-1 receptor, which is often increased in many human cell lines \[[@B69]--[@B72]\]. Therefore, impaired and/or prolonged UPR has a high potential to modulate cell fates and differentiations towards tumorigenesis.

Alcohol intake increasingly contributes to mortality from liver cancer in humans \[[@B73]--[@B76]\]. However, the mechanisms by which alcohol exerts its carcinogenic effect are largely unknown and currently there is no effective treatment. Considering that several lines of evidence indicate that polymorphic responses of major ER chaperones to alcohol and other stressors are associated with hepatocellular carcinogenesis in human populations \[[@B77]--[@B82]\], it is not unusual to find a role of AERR in HCC. In fact, we recently found spontaneous hepatocellular adenomas- (HCA-) like tumors in aged female mice with a liver specific BiP deletion and under constitutive ER stress \[[@B31], [@B59], [@B83]\]. Active ATF6, CHOP, GSK3*β*, and Creld2 (cysteine rich with EGF-like domains 2) were increased in the knockout, indicative of continuous ER stress response. None of p53, HNF1*α*, or GP130 was significantly changed compared between wild type and knockout. *β*-Catenin was slightly decreased. Interestingly, cyclin D was specifically reduced in the tumor portion of the knockout mice. Since most liver tumors were found in female knockouts, expression of receptors for sex hormones such as estrogen receptors, ER*α* and *β*, and androgen receptor, AR*α*, was examined. Three variants of ER*α* were detected in the liver, and their molecular sizes are 66 kD, 46 kD, and 36 kD, respectively \[[@B83]\]. The ER*α* variant 36 kD was remarkably increased in the tumor portion of the knockout liver. In contrast, there were no significant changes in the expression of ER*β*, AR*α*, cyclin E, or cyclin G. These findings revealed thatinhibition of cyclin D and overexpression of ER variant 36 kD are associated with the tumor development in the female knockouts under constitutive ER stress \[[@B83]\]. Furthermore, the tumors are highly malignant in mice with additional stresses such as high-fat diet or alcohol intake \[[@B83], [@B84]\]. The pathways of ERK1/2, Stat3, and p38 were activated, which are known to promote HCC progression \[[@B85], [@B86]\].

The constitutive ER stress-induced spontaneous liver tumors that are dominant in female animals are similar to human HCA \[[@B87]--[@B90]\], which are of clinical relevance since about 80% of HCA cases are from women taking oral contraceptives for years \[[@B90], [@B91]\]. The pathogenesis of HCA is not completely understood due to its heterogeneity. Known potential causesfor human HCA are mutations in HNF1*α*, *β*-catenin, GP130, or chronic inflammation \[[@B87]--[@B93]\]. Hepatocellular protein homeostasis has rarely been noticed to be a potential mechanism for HCA development. Thus, the above findings on cyclin D and ER*α* variants may reveal a novel ER stress mechanism for HCA for several reasons ([Figure 2](#fig2){ref-type="fig"}). First, the*in vivo* inhibition of cyclin D expression upon ER stress in knockouts is consistent with an earlier study, which demonstrated that activation of the UPR in mouse NIH 3T3 fibroblasts with tunicamycin led to a decline in cyclin D and subsequent G(1) phase arrest \[[@B94]--[@B96]\]. Second, increased expression of cyclin D is usually associated with proliferation in other systems \[[@B97]\]. However, a number of studies have shown many new roles of cyclin D \[[@B98]\] and a surprising lack of the correlation of increased cyclin D with proliferation in tumors \[[@B99], [@B100]\]. For instance, in one subtype of human breast carcinoma, cyclin D1 protein expression was absent in the noninvasive cells \[[@B101], [@B102]\]. Similarly, a loss of cyclin D did not inhibit the proliferative response of mouse liver to mitogenic stimuli \[[@B103]\] and mRNA levels of cyclin D1 were downregulated in patients with HCC \[[@B104]\]. Most recent molecular evidence further supports this ER stress-cyclin D-tumorigenesis mechanism. Nrf2 (the nuclear factor erythroid 2-related factor 2) activities are associated with aging \[[@B105]\]. ER stress activates Nrf2 and ATF6, both of which regulate the orphan nuclear receptor, Shp (small heterodimer partner) which acts as a transcriptional corepressor modulating cyclin D1 and subsequent hepatic tumorigenesis \[[@B106], [@B107]\]. The ER stress sensor PERK has been shown to phosphorylate the Forkhead transcription factor 3 (FOXO3) \[[@B108]\] and suppressed FOXO3 exacerbates alcoholic hepatitis and insulin resistance impairing cyclin D function promoting HCC \[[@B109]--[@B111]\]. Thus, abnormal functions of cyclin D under ER stress conditions most likely disturb liver cell proliferation ([Figure 2](#fig2){ref-type="fig"}). Third, since the authentic ER*α*66 interacts with cyclin D physically \[[@B100], [@B101]\], the hepatic ER*α* variants may result from an unbalanced long-term molecular interaction between ER*α* and the suppressed cyclin D under ER stress ([Figure 2](#fig2){ref-type="fig"}). Alternatively, the ER*α* variants may be produced from an incomplete protein processing/maturation of ER*α* by an impaired ER-associated degradation (ERAD). Components of ERAD are indeed altered in the BiP knockout mouse models under constitutive UPR \[[@B31], [@B59], [@B83], [@B84]\], and there is a report indicating that an activation of the Xbp1-Hrd1 (an E3 ubiquitin ligase also called synoviolin) branch by the UPR facilitates Nrf2 ubiquitylation and degradation during liver cirrhosis \[[@B112]\]. Similarly, ER*α* could also be a target of the impaired ERAD. Fourth, considering that ER*α* gene polymorphism is associated with risk of HBV-related acute liver failure \[[@B113]\] and a switch from the authentic ER*α* to a predominant expression of ER*α*36 is associated with development and progression of HCC \[[@B114]--[@B116]\], the hepatic ER*α* variants could also play an important role in alcohol and ER stress-associated HCC. The tumorigenic signaling downstream of cyclin D and ER*α* variants can be activations of the ERK1/2, IP3K-PKC, or JAK-STAT pathways \[[@B117]\]. Overexpressed ER*α*36 has been associated with activation of these pathways and carcinogenesis in other systems such as breast cancer and gastric cancer \[[@B118]--[@B122]\]. In the liver, activations of ERK1/2 and JAK-STAT pathways were observed in the BiP knockout mice fed alcohol and high-fat diet \[[@B83], [@B84]\]. Finally, studies on hepatoma cell lines, HCC tissues, and animal models of HCC suggest a possible role of sex hormones and their receptors in HCC pathogenesis \[[@B123]\]. A male prevalence of HCC is often observed in young and middle aged patient populations in certain regions exposed to additional HCC risk factors \[[@B124]\]. However, the male prevalence of HCC tends to diminish in aged human populations \[[@B125]\] as well as in aged animals fed alcohol \[[@B83], [@B84]\]. Therefore, alcohol-induced ER stress and cell cycle impairment may exert specific effects on aging, hepatic expression of estrogen receptors, and subsequent tumorigenesis in females.

5. Conclusive Remarks {#sec5}
=====================

Alcohol-induced hepatic ER stress occurs in the liver of many species including human alcoholics, which has recently been established as an important mechanism for both acute and chronic alcohol-induced liver pathogenesis and disease development. Multiple factors commonly associated with alcohol consumption such as acetaldehyde, oxidative stress, excessive homocysteine, toxic lipid species, increased SAH, aberrant epigenetic modifications, disruption of calcium homeostasis, and insulin resistance induce ER stress response individually or collectively. However, the precise contribution of each of the factors to the ER stress induction is not clear and their importance to ALD may depend on doses, duration and patterns of alcohol exposure, presence or absence of genetic and environmental factors, cross-talks with other pathogenic pathways, and liver disease stages. The UPR, as an integrated part of liver physiology and pathology like the immune response, may occur more or less all the time during alcohol consumption, which attempts to restore ER homeostasis and protect against ALD. However, this adaptive protection is not without detrimental consequences. Prolonged UPR leads to excessive deletion of the damaged hepatocytes or cell cycle arrest, which triggers inflammatory response or interrupts normal cellular processes causing profound injuries. Emerging evidence by us and others indicates a direct involvement of long-term alcohol and constitutive ER stress in liver tumorigenesis and hepatocellular carcinogenesis. The ER stress and malfunctioning of cyclin D-caused cell cycle arrest are a well-established molecular mechanism, and the surprise overexpression of estrogen receptor *α* variants under constitutive UPR may result from a mal-targeting of protein processing and turnover by aberrant ERAD, which reflect complexity and depth of prolonged UPR-mediated pathogenesis. Thus, liver tumorigenesis by alcohol and ER stress may involve not only cyclin D, ER*α* variants, ERK1/2, PKC, and STAT pathways, but also other cell cycle targets such as IL-6, p21, p27, and CDK, other pathways such as Src/EGFR, PTEN-TGF*β*, and insulin/IGF, and epigenetic regulations such as miRNAs targeting the UPR components. In addition, liver progenitor cell activation by alcohol may contribute to the malignant transformation of nonmalignant tumors developed under long-term ER stress \[[@B31], [@B59]\]. Future work should be directed to define the ER stress mechanisms leading to HCC and to develop multiple therapeutic approaches to target ER stress in human alcoholics with HCC.

This work is supported by the US National Institute of Health (NIH) Grants R01AA018612, R01AA014428, and R01AA018846. The author is grateful to the graduate students and postdoctoral fellows who contributed to the studies in his lab.

ADH:

:   Alcohol dehydrogenase

AERR:

:   Alcohol-induced ER stress response

ALD:

:   Alcohol-induced liver disease

AR*α*:

:   Androgen receptor *α*

ASMase:

:   The acid sphingomyelinase

ATF 4 or 6:

:   Activating transcription factor 4 or 6

BAD:

:   The Bcl-2-associated death promoter

BiP:

:   Binding immunoglobulin protein also known as 78 kDa glucose-regulated protein (GRP78)

BHMT:

:   Betaine-homocysteine methyltransferase

CBS:

:   Cystathionine *β* synthase

CDIPT:

:   CDP-diacylglycerol-inositol 3-phosphatidyltransferase

CDK:

:   Cyclin-dependent kinase

CHOP:

:   C/EBP homology protein 10

CIAI:

:   Chronic intragastric alcohol infusion

Creld2:

:   Cysteine rich with EGF-like domains 2

EGFR:

:   Activation of the epidermal growth factor receptor

ER:

:   Endoplasmic reticulum

ER*α*:

:   Estrogen receptors *α*

ERAD:

:   ER-associated degradation

ERK1/2:

:   Extracellular signal-regulated protein kinases 1 and 2

FOXO3:

:   The forkhead transcription factor

HCA:

:   Hepatocellular adenomas

HCC:

:   Hepatocellular carcinogenesis

HERP:

:   Homocysteine-induced ER protein

HFD:

:   High-fat diet

HHcy:

:   Hyperhomocysteinemia

4-HNE:

:   4-Hydroxynonenal

HNF1*α*:

:   Hepatocyte nuclear factor 1*α*

Hrd1:

:   An E3 ubiquitin ligase also called synoviolin

GADD34:

:   Growth arrest and DNA damage-inducible protein 34

GSH:

:   Glutathione

GP130:

:   Glycoprotein 130

GSK3*β*:

:   Glycogen synthase kinase 3*β*

IGF:

:   Insulin-like growth factor

IRE1*α*:

:   Inositol-requiring enzyme-1*α*

IRF3:

:   The interferon regulatory factor 3

JAK:

:   Janus kinase

JNK:

:   c-Jun N-terminal kinases

LC3:

:   Microtubule-associated protein 1A/1B-light chain 3

LPS:

:   Lipopolysaccharides

Mito:

:   Mitochondria

MDDC:

:   Human monocyte-derived dendritic cells

MEOS:

:   The inducible microsomal ethanol oxidizing system

mTOR:

:   Mammalian target of rapamycin

NF*κ*B:

:   Nuclear factor *κ*B

PDI:

:   The ER disulfide isomerase

Nrf2:

:   The nuclear factor erythroid 2-related factor 2

PGC1:

:   PPAR*γ* coactivator 1

PERK:

:   PKR-like ER-localized eIF2*α* kinase

PKC:

:   Protein kinase C

PTEN:

:   Phosphatase and tensin homolog

ROS:

:   Reactive oxygen species

SAH:

:   S-Adenosylhomocysteine

SAM:

:   S-Adenosylmethionine

SERCA:

:   ER calcium transport ATPase

Shp:

:   Small heterodimer partner

SIRT1:

:   Silent mating type information regulation 2 homolog 1

SRC:

:   Protooncogene tyrosine-protein kinase

SREBP:

:   Sterol regulatory element-binding protein

STING:

:   An ER adaptor, the stimulator of interferon genes

Stat3:

:   Signal transducer and activator of transcription 3

TGF*α*:

:   Transforming growth factor *α*

TLR4:

:   Toll-like receptor 4

TRB3:

:   A mammalian homolog of*Drosophila* tribbles functions as a negative modulator of protein kinase B (PKB)

TRAF2:

:   TNF receptor-associated factor 2

TUDCA:

:   Tauroursodeoxycholate

UPR:

:   The unfolded protein response

VEGF:

:   Vascular endothelial growth factor

XBP1:

:   X-box binding protein 1.

Conflict of Interests
=====================

The author declares that there is no conflict of interests regarding the publication of this paper.

![Identified molecular mechanisms for alcohol-induced endoplasmic reticulum stress and hepatic injuries. See the context for details.](IJH2014-513787.001){#fig1}

![Proposed model depicts novel endoplasmic reticulum (ER) stress mechanisms linking alcohol (EtOH) and/or high-fat diet (HFD), cyclin D, ERAD, estrogen receptor *α* (ER*α*) variants, FOXO3, and Shp with hepatocellular carcinogenesis (HCC). Solid lines represent established pathways based on the literature; dashed lines represent emerging mechanisms under investigations. See the context for details.](IJH2014-513787.002){#fig2}

###### 

Alcohol-induced endoplasmic reticulum stress (AERR) and injuries occur in many species.

  Experimental system             Cause                   Injury                           Remark                                 Reference
  ------------------------------- ----------------------- -------------------------------- -------------------------------------- ----------------------
  Chronic intragastric infusion                                                                                                    
   Mouse                          Hyperhomocysteinemia    Necroinflammation                Mouse strain difference                \[[@B15]--[@B17]\]
   Methionine deficiency           Apoptosis               Rat and mouse difference        \[[@B22]--[@B26]\]                     
  Acetaldehyde adducts            Fatty liver             Synergy with obesity             \[[@B27]\]                             
   Rat                             High SAH                Fibrosis                                                               \[[@B28]\]
  Low SAM/SAH                                                                                                                     
  Epigenetic alterations                                                                                                          
  Chronic oral feeding                                                                                                             
   Micropig                       Folate deficiency       Steatosis                                                               \[[@B30]\]  
   Mouse                          Chaperone deficiency    Apoptosis                        Interaction of alcohol with            \[[@B31]\]  
  Synergy with HFD/drugs          Fibrosis                anti-HIV/HCV drugs               \[[@B32]\]                             
  Excess iron                     Cirrhosis               Involvement of autophagy         \[[@B33], [@B34]\]                     
  Oxidative stress                                        Oxidative stress precedes AERR   \[[@B35], [@B36]\]                     
  Acute alcohol exposure                                                                                                           
   Liver perfusion                Acetaldehyde, ROS       Fat accumulation                 Role of alcohol metabolites in AERR    \[[@B37]\]  
   Mouse gavage                   Synergy with drugs      Apoptosis                                                               \[[@B31]\]  
  Ca^2+^ homeostasis              Fibrosis                 AERR parallels LPS-TLR4         \[[@B40], [@B41]\]                     
  Inflammation                                            Suppressed UPR                   \[[@B42]\]                             
   Zebrafish                      CDIPT deficiency        Hepatomegaly                                                            \[[@B44]--[@B46]\]  
   Nematode                       Not known               Not characterized                No AERR without the liver              \[[@B47]\]
  Alcohol treated cells                                                                                                            
   Human cells                    ROS                     Apoptosis                        Basal ER stress in HepG2               \[[@B48]--[@B50]\]
  Excessive homocysteine          Steatosis                                                                                       
  Patient liver biopsies                                                                                                           
   Human alcoholics               Toxic lipid species     Apoptosis                        Clinical relevance                     \[[@B51]--[@B54]\]
  Oxidative stress                Steatohepatitis         Role of mitochondrial                                                   
  Insulin resistance              Fibrosis/cirrhosis      Dysfunctions in AERR                                                    

[^1]: Academic Editor: Shigeru Marubashi
